Vir(VIR) - 2024 Q1 - Earnings Call Transcript

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Sasha Damouni Ellis - Executive Vice President, Chief Corporate Affairs Officer Marianne De Backer - Chief Executive Officer Carrie Huang - Senior Vice President, Clinical Research and Interim Chief Medical Officer Sung Lee - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Paul Choi - Goldman Sachs Alec Stranahan - Bank of America Phil Nadeau - TD Cowen Patrick Trucchio ...